Artificial Intelligence driven Marketing Communications
Market Research Report Store offers a latest published report on Renin-Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Click to view the full report TOC, figure and tables:
Global Renin Inhibitors Market Is Expected To Reach USD 116.94 Million By 2025, Growing At A CAGR Of More Than 6.74% From USD 69.39 Million In 2017
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
The major players in global Renin-Inhibitors market include: Novartis, Noden Pharma.
On the basis of product, the Renin-Inhibitors market is primarily split into: 150mg/Tablet, 300mg/Tablet.
On the basis on the end users/applications, this report covers: Age below 45, Age 45-55, Age 55-65, Age above 65.
Renin inhibitors are a group of pharmaceutical drugs used primarily in treatment of essential hypertension (high blood pressure). Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
Tekturna is a mature product and had peak sales of $557m in 2011. However, In the past few years, renin inhibitors (Tekturna) market suffered very noticeable decline as a result of possible risks when using blood pressure medicines containing aliskiren with other drugs called angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients with diabetes or kidney (renal) impairment issued by FDA in 2012.
GIR analysis of the renin inhibitors market indicated that the global renin inhibitors market is expected to reach USD 116.94 million by 2025, growing at a CAGR of more than 6.74% from USD 69.39 million in 2017; the actual sales are about 40.98 million tablets in 2017.
USA is still the largest consumption region of Tekturna, occupied about 56% market share globally, with revenue 39.21 million USD in 2017. At the same time, Asia will see the considerable growth since Noden Pharma DAC had successfully entered into an agreement with Orphan Pacific (Japan) and Lee’s Pharmaceutical Holdings Limited (China).
For More Information On This Report, Please Visit @
North America Renin-Inhibitors Market Growth 2019-2024
United States Renin-Inhibitors Market Growth 2019-2024
Asia-Pacific Renin-Inhibitors Market Growth 2019-2024
Europe Renin-Inhibitors Market Growth 2019-2024
EMEA Renin-Inhibitors Market Growth 2019-2024
Global Renin-Inhibitors Market Growth 2019-2024
China Renin-Inhibitors Market Growth 2019-2024
Customization Service of the Report :
Market Research Report Store provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.
Market Research Report Store (MRRS) is a professional organization related to market research reports in all directions .To provide customers with a variety of market research reports, MRRS cooperates with a large of famous market report publishers all over the world. Owing to our good service and the professional market reports in the wide range, MRRS enjoys a good reputation in the market. In pace with the development of MRRS, more and more customers and market report publishers choose to cooperate with us. As a specialized platform, MRRS upholds the supremacy of customers and aims to provide customers with better service and richer select.